ImmunologybioRxivPreprint
Matching or genetic engineering of HLA Class I and II facilitates successful allogeneic 'off-the-shelf' regulatory T cell therapy
O. McCallion, W. Du, V. Glaser…·F. Issa
This study shows that matching or engineering HLA-I and HLA-II improves the efficacy of allogeneic regulatory T cells for immunoregulation.
DOI 10.1101/2023.08.06.551956